{"id":"https://openalex.org/W2001200601","doi":"https://doi.org/10.1097/00004714-199808000-00010","title":"Plasma Prolactin and Central D2 Receptor Occupancy in Antipsychotic Drug-Treated Patients","display_name":"Plasma Prolactin and Central D2 Receptor Occupancy in Antipsychotic Drug-Treated Patients","alternate_titles":[],"publication_year":1998,"publication_date":"1998-08-01","ids":{"openalex":"https://openalex.org/W2001200601","doi":"https://doi.org/10.1097/00004714-199808000-00010","mag":"2001200601","pmid":"https://pubmed.ncbi.nlm.nih.gov/9690696"},"language":"en","primary_location":{"id":"doi:10.1097/00004714-199808000-00010","doi":"https://doi.org/10.1097/00004714-199808000-00010","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-199808000-00010","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2001200601"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044763213","display_name":"Anna Nordstr\u00f6m","orcid":"https://orcid.org/0000-0003-3534-456X","observed_orcids":["https://orcid.org/0000-0003-3534-456X"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Anna-Lena Nordstrom","raw_affiliation_strings":["Department of Clinical Neuroscience, Karolinska Hospital, Stockholm, Sweden","Anna-Lena Nordstrom, MD, PhD, Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, S-171 76 Stockholm, Sweden","Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Neuroscience, Karolinska Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]},{"raw_affiliation_string":"Anna-Lena Nordstrom, MD, PhD, Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, S-171 76 Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]},{"raw_affiliation_string":"Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061483789","display_name":"Lars Farde","orcid":"https://orcid.org/0000-0003-1297-0816","observed_orcids":["https://orcid.org/0000-0003-1297-0816"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lars Farde","raw_affiliation_strings":["Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5044763213"],"corresponding_institution_ids":["https://openalex.org/I1335113835"],"apc_list":null,"apc_paid":null,"fwci":1.6938,"has_fulltext":false,"cited_by_count":79,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.82512873,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"18","issue":"4","first_page":"305","last_page":"310"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plasma-prolactin","display_name":"plasma prolactin","score":0.9160000085830688},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-occupancy","display_name":"dopamine D2 receptor occupancy","score":0.9350000023841858},{"id":"https://openalex.org/keywords/raclopride","display_name":"raclopride","score":0.9290000200271606},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8529999852180481},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/low-dose-antipsychotics","display_name":"low-dose antipsychotics","score":0.859000027179718},{"id":"https://openalex.org/keywords/antipsychotic-effects","display_name":"antipsychotic effects","score":0.7770000100135803},{"id":"https://openalex.org/keywords/positron-emission-tomography","display_name":"positron emission tomography","score":0.8180000185966492},{"id":"https://openalex.org/keywords/drug-monitoring","display_name":"drug monitoring","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C2781069445","wikidata":"https://www.wikidata.org/wiki/Q7279814","display_name":"Raclopride","level":4,"score":0.7841110229492188},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7203742265701294},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.6901381015777588},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.6108266711235046},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5872939229011536},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5380634069442749},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.48313137888908386},{"id":"https://openalex.org/C3019878999","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic drug","level":4,"score":0.42385947704315186},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40530669689178467},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.396179735660553},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3416252136230469},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2867127060890198},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.24166080355644226},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.2053077220916748}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011388","descriptor_name":"Prolactin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012457","descriptor_name":"Salicylamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012457","descriptor_name":"Salicylamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D012457","descriptor_name":"Salicylamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014055","descriptor_name":"Tomography, Emission-Computed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020891","descriptor_name":"Raclopride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004714-199808000-00010","doi":"https://doi.org/10.1097/00004714-199808000-00010","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-199808000-00010","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:9690696","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9690696","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6429985181","display_name":null,"funder_award_id":"41205-11","funder_id":"https://openalex.org/F4320332505","funder_display_name":"U.S. Public Health Service"}],"funders":[{"id":"https://openalex.org/F4320332505","display_name":"U.S. Public Health Service","ror":"https://ror.org/05xf94514"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W95583342","https://openalex.org/W162223338","https://openalex.org/W1545136637","https://openalex.org/W1787454655","https://openalex.org/W1981964004","https://openalex.org/W1983810843","https://openalex.org/W1984229889","https://openalex.org/W1985050254","https://openalex.org/W1991724312","https://openalex.org/W1995555785","https://openalex.org/W2005890460","https://openalex.org/W2005957877","https://openalex.org/W2020682977","https://openalex.org/W2020844317","https://openalex.org/W2022192313","https://openalex.org/W2023760984","https://openalex.org/W2046565424","https://openalex.org/W2053736519","https://openalex.org/W2057132504","https://openalex.org/W2064090763","https://openalex.org/W2064797152","https://openalex.org/W2071763279","https://openalex.org/W2072069319","https://openalex.org/W2073793680","https://openalex.org/W2077760177","https://openalex.org/W2113318993","https://openalex.org/W2143663838","https://openalex.org/W2147624584","https://openalex.org/W2162046522","https://openalex.org/W2396518560","https://openalex.org/W2433319170"],"related_works":["https://openalex.org/W1984229889","https://openalex.org/W1981964004","https://openalex.org/W2083946354","https://openalex.org/W1991724312","https://openalex.org/W2099185967","https://openalex.org/W2150382103","https://openalex.org/W2022064085","https://openalex.org/W1996707692","https://openalex.org/W2038109981","https://openalex.org/W2062069193"],"abstract_inverted_index":{"Previous":[0],"studies":[1,28,178],"of":[2,36,103,141,157,183,190,200],"the":[3,43,62,91,138,155,167],"relationship":[4,44],"between":[5,45],"plasma":[6,46,146,191],"prolactin":[7,47,97,132,192],"and":[8,49,82,166],"clinical":[9,198],"effects":[10],"in":[11,56,101,197],"patients":[12,59,105,119],"treated":[13,60],"with":[14,61,106,120,145],"antipsychotic":[15,64,86,168,184,201],"drugs":[16,185],"have":[17,29],"yielded":[18],"inconsistent":[19],"results.":[20],"A":[21],"possible":[22],"explanation":[23],"may":[24,186],"be":[25],"that":[26,179],"most":[27],"not":[30],"included":[31],"subtherapeutic":[32],"or":[33,69],"low":[34,181],"doses":[35,182],"antipsychotics.":[37],"In":[38],"this":[39],"exploratory,":[40],"double-blind":[41],"study,":[42],"concentration":[48,98,133,148],"central":[50],"D2":[51,73,108,122,158],"receptor":[52,74,109,123,159],"occupancy":[53,75,110,124,160],"was":[54,76,83,99,116],"examined":[55],"13":[57],"schizophrenic":[58],"experimental":[63],"drug":[65,202],"raclopride":[66,142,147],"(2,":[67],"6,":[68],"12":[70],"mg":[71],"daily).":[72],"determined":[77],"by":[78,90],"positron":[79],"emission":[80],"tomography":[81],"related":[84],"to":[85],"effect":[87,169],"as":[88,193],"measured":[89,134],"Brief":[92],"Psychiatric":[93],"Rating":[94],"Scale.":[95],"Plasma":[96,131],"increased":[100],"eight":[102],"nine":[104],"a":[107,121,188,194],"greater":[111],"than":[112,126],"50%,":[113],"whereas":[114],"it":[115],"normal":[117],"among":[118],"less":[125],"50%":[127],"(p":[128],"<":[129,153,164,174],"0.01).":[130,175],"4":[135],"hours":[136],"after":[137],"morning":[139],"dose":[140],"correlated":[143],"significantly":[144],"(r":[149,161,170],"=":[150,162,171],"0.92,":[151],"p":[152,173],"0.01),":[154,165],"degree":[156],"0.81,p":[163],"0.79,":[172],"Further":[176],"controlled":[177],"include":[180],"warrant":[187],"reconciliation":[189],"useful":[195],"tool":[196],"monitoring":[199],"treatment.":[203]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2001200601","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
